Skip to main content
SpringerLink
Log in

Programmed Death-1 Gene Polymorphisms in Patients With Systemic Lupus Erythematosus in Taiwan

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

To investigate the role of programmed cell death-1 (PD-1) gene polymorphisms in the development of systemic lupus erythematosus (SLE) in Taiwan, 109 patients with SLE and 100 healthy controls were enrolled in this study. The PD-1 gene polymorphisms were determined by the method of polymerase chain reaction/restriction fragment length polymorphism. This study showed that the genotype distributions of PD-1 7209 C/T polymorphisms were significantly different between the patients with SLE and controls (P=0.002, Pc=0.018). The frequencies of the PD-1 7209 C/C genotype and PD-1 7209 C allele were significantly higher in the patients with SLE than those of the controls (P=0.001, OR=2.6, 95% CI=1.5–4.6, and P=0.002, OR=2.1, 95% CI=1.3–3.4, Pc=0.018, respectively). Moreover, the association of PD-1 7209 C with susceptibility to SLE was independent of the PD-1 ligand. This study also showed that the PD-1-536 A 7146 G 7209 C 7499 G haplotype was associated with the development of SLE in Taiwan.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Tsao BP: Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16(5):513–521, 2004

    Article  PubMed  CAS  Google Scholar 

  2. Prokunina L, Alarcon-Riquelme M: The genetic basis of systemic lupus erythematosus—Knowledge of today and thoughts for tomorrow. Hum Mol Genet 13 (Special Issue 1):R143–148, 2004

    Article  PubMed  CAS  Google Scholar 

  3. Moser KL, Neas BR, Salmon JE et al.: Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 95(25):14869–14874, 1998

    Article  PubMed  CAS  Google Scholar 

  4. Croker JA, Kimberly RP: Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 17(5):529–537, 2005

    Article  PubMed  CAS  Google Scholar 

  5. Ishida Y, Agata Y, Shibahara K, Honjo T: Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11(11):3887–3895, 1992

    PubMed  CAS  Google Scholar 

  6. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T: PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 98(24):13866–13871, 2001

    Article  PubMed  CAS  Google Scholar 

  7. Freeman GJ, Long AJ, Iwai Y et al.: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192(7):1027–1034, 2000

    Article  PubMed  CAS  Google Scholar 

  8. Latchman Y, Wood CR, Chernova T et al.: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2(3):261–268, 2001

    Article  PubMed  CAS  Google Scholar 

  9. Nishimura H, Nose M, Hiai H, Minato N, Honjo T: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11(2):141–151, 1999

    Article  PubMed  CAS  Google Scholar 

  10. Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T: Establishment of NOD-Pdcd1−/− mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci USA 102(33):11823–11828, 2005

    Article  PubMed  CAS  Google Scholar 

  11. Ansari MJ, Salama AD, Chitnis T et al.: The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 198(1):63–69, 2003

    Article  PubMed  CAS  Google Scholar 

  12. Nishimura H, Okazaki T, Tanaka Y et al.: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291(5502):319–322, 2001

    Article  PubMed  CAS  Google Scholar 

  13. Okazaki T, Tanaka Y, Nishio R et al.: Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 9(12):1477–1483, 2003

    Article  PubMed  CAS  Google Scholar 

  14. Lindqvist AK, Steinsson K, Johanneson B et al.: A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 14(2):169–178, 2000

    Article  PubMed  CAS  Google Scholar 

  15. Magnusson V, Lindqvist AK, Castillejo-Lopez C et al.: Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. Genomics 70(3):307–314, 2000

    Article  PubMed  CAS  Google Scholar 

  16. Prokunina L, Castillejo-Lopez C, Oberg F et al.: A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32(4):666–669, 2002

    Article  PubMed  CAS  Google Scholar 

  17. Ferreiros-Vidal I, Gomez-Reino JJ, Barros F et al.: Association of PDCD1 with susceptibility to systemic lupus erythematosus: Evidence of population-specific effects. Arthritis Rheum 50(8):2590–2597, 2004

    Article  PubMed  CAS  Google Scholar 

  18. Johansson M, Arlestig L, Moller B, Rantapaa-Dahlqvist S: Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum 52(6):1665–1669, 2005

    Article  PubMed  CAS  Google Scholar 

  19. Prokunina L, Padyukov L, Bennet A et al.: Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 50(6):1770–1773, 2004

    Article  PubMed  CAS  Google Scholar 

  20. Kong EK, Prokunina-Olsson L, Wong WH et al.: A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 52(4):1058–1062, 2005

    Article  PubMed  CAS  Google Scholar 

  21. Lin SC, Yen JH, Tsai JJ et al.: Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 50(3):770–775, 2004

    Article  PubMed  CAS  Google Scholar 

  22. Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST: Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62(6):492–497, 2003

    Article  PubMed  CAS  Google Scholar 

  23. Kroner A, Mehling M, Hemmer B et al.: A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58(1):50–57, 2005

    Article  PubMed  CAS  Google Scholar 

  24. Prokunina L, Gunnarsson I, Sturfelt G et al.: The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 50(1):327–328, 2004

    Article  PubMed  CAS  Google Scholar 

  25. Chou WC, Liao KW, Lo YC, Jiang SY, Yeh MY, Roffler SR: Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells. Biotechnol Bioeng 65(2):160–169, 1999

    Article  PubMed  CAS  Google Scholar 

  26. Choi S, Lee E, Kwon S et al.: Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4. J Biol Chem 280(52):42573–42579, 2005

    Article  PubMed  CAS  Google Scholar 

  27. Bourguignon LY, Singer SJ: Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands. Proc Natl Acad Sci USA 74(11):5031–5035, 1977

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

    SHU-CHEN WANG

  2. College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

    YI-JING CHEN, WEN-CHAN TSAI & HONG-WEN LIU

  3. Department of Internal Medicine, Kaohsiung Medical University Hospital, Division of Rheumatology, 100 Zihyou 1st Road, Kaohsiung City, 807, Taiwan

    TSAN-TENG OU, CHENG-CHIN WU, WEN-CHAN TSAI, HONG-WEN LIU & JENG-HSIEN YEN

  4. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

    JENG-HSIEN YEN

Authors
  1. SHU-CHEN WANG
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. YI-JING CHEN
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. TSAN-TENG OU
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. CHENG-CHIN WU
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. WEN-CHAN TSAI
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. HONG-WEN LIU
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. JENG-HSIEN YEN
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to JENG-HSIEN YEN.

Additional information

Both Authors Contributed equally to this work

Rights and permissions

Reprints and permissions

About this article

Cite this article

WANG, SC., CHEN, YJ., OU, TT. et al. Programmed Death-1 Gene Polymorphisms in Patients With Systemic Lupus Erythematosus in Taiwan. J Clin Immunol 26, 506–511 (2006). https://doi.org/10.1007/s10875-006-9048-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-006-9048-9

KEY WORDS:

Search

Navigation